DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Developing a Mobile Method to Measure THC-induced Impairment

Early Phase 1

Completed

Conditions: Measuring THC-induced Cognitive Impairment Using a Mobile Application

Interventions: Drug: Placebo
Drug: Dronabinol

First Posted Date: 2019-01-15

Last Posted Date: 2019-01-15

Lead Sponsor: University of Chicago

Target Recruit Count: 48

Registration Number: NCT03804840

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Effect of Stimulant Drugs on Social Perception

Phase 1

Completed

Conditions: Healthy
MDMA ('Ecstasy')

Interventions: Drug: 3,4-Methylenedioxymethamphetamine
Drug: methamphetamine

First Posted Date: 2018-12-31

Last Posted Date: 2024-01-05

Lead Sponsor: University of Chicago

Target Recruit Count: 36

Registration Number: NCT03790618

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Mood Effects of Serotonin Agonists

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Lysergic Acid Diethylamide

First Posted Date: 2018-12-31

Last Posted Date: 2024-01-24

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT03790358

Locations: 🇺🇸
Matthew Bona, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD

Phase 1

Terminated

Conditions: Heart Failure
Gastrointestinal Bleeding

Interventions: Other: Placebo
Drug: Omega 3 fatty acids

First Posted Date: 2018-12-24

Last Posted Date: 2021-07-13

Lead Sponsor: University of Chicago

Target Recruit Count: 35

Registration Number: NCT03784963

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)

Completed

Conditions: Atrial Fibrillation

First Posted Date: 2018-11-13

Last Posted Date: 2024-05-07

Lead Sponsor: University of Chicago

Target Recruit Count: 29

Registration Number: NCT03737838

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Azithromycin Treatment for the Airway Microbiome in Asthma

Phase 2

Terminated

Conditions: Asthma Chronic

Interventions: Drug: Placebo
Drug: Azithromycin

First Posted Date: 2018-11-09

Last Posted Date: 2023-08-23

Lead Sponsor: University of Chicago

Target Recruit Count: 17

Registration Number: NCT03736629

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)

Phase 3

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Carfilzomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Bortezomib

First Posted Date: 2018-11-05

Last Posted Date: 2025-01-27

Lead Sponsor: University of Chicago

Target Recruit Count: 250

Registration Number: NCT03729804

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: Magnetic Resonance Imaging (MRI)

First Posted Date: 2018-11-02

Last Posted Date: 2023-08-03

Lead Sponsor: University of Chicago

Target Recruit Count: 400

Registration Number: NCT03729115

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery

Not Applicable

Recruiting

Conditions: Surgery

Interventions: Procedure: Routine Elective Surgery- In patient or out patient elective surgery
Diagnostic Test: Blood test for genetic testing
Other: Drug-genetic Profile

First Posted Date: 2018-11-02

Last Posted Date: 2025-02-05

Lead Sponsor: University of Chicago

Target Recruit Count: 1900

Registration Number: NCT03729180

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Effect of Noninvasive Electrical Brain Stimulation on Memory at Different Times of Day in Younger and Older Adults

Not Applicable

Completed

Conditions: Effect of tDCS on Memory in Older and Younger Adults

Interventions: Device: Active tDCS
Device: Sham tDCS

First Posted Date: 2018-10-30

Last Posted Date: 2024-05-14

Lead Sponsor: University of Chicago

Target Recruit Count: 271

Registration Number: NCT03723850

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy